Abstract:Background: With the rapid global spread of COVID-19, it has become evident that the virus can lead to multisystem complications, leading to a significant increase in related publications. Bibliometrics serves as a valuable tool for identifying highly cited literature and research hotspots within specific areas. Objective: The aim of this study is to identify current research hotspots and future trends in COVID-19 complications. Methods: The dataset was obtained from the Web of Science Core Collection, covering COVID-19 complications from December 8, 2019, to October 31, 2022. Various aspects, including publication general information, authors, journals, co-cited authors, co-cited references, research hotspots, and future trends, were subjected to analysis. Visual analysis was conducted using VOSviewer, The Online Analysis Platform of Literature Metrology, and Charticulator. Results: There were 4597 articles in the study. The top three countries with the most published articles are the USA (n = 1350, 29.4 %), China (n = 765, 16.6 %), and Italy (n = 623, 13.6 %). USA and China have the closest collaborative relationship. The institute with the largest number of publications is Huazhong University of Science and Technology, followed by Harvard Medical School. Nevertheless, half of the top 10 institutes belong to the USA. "Rezaei, Nima" published 13 articles and ranked first, followed by "Yaghi, Shadi" with 12 articles and "Frontera, Jennifer" with 12 articles. The journal with the largest number of publications is "Journal of Clinical Medicine". The top 3 co-cited authors are "Zhou, Fei", "Guan, Wei-Jie", "Huang, Chaolin". The top 3 co-cited references addressed COVID-19's clinical features in China and noticed that COVID-19 patients had a wide range of complications. We also list four research hotspots. Conclusions: This study conducted a bibliometric visual analysis of the literature on COVID-19 complications and summarized the current research hotspots. This study may provide valuable insights into the complications of COVID-19.

Multi-omics for COVID-19: driving development of therapeutics and vaccines.

Multi-omics in COVID-19: Driving development of therapeutics and vaccines

Multiomics: Unraveling the Panoramic Landscapes of SARS-CoV-2 Infection

Multiomics integration-based molecular characterizations of COVID-19

The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets

Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.

Towards precision medicine: Omics approach for COVID-19

Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19

Multi-omics study revealing putative drug targets of COVID-19 severity and other viral infection diseases

Immunomics in one health: understanding the human, animal, and environmental aspects of COVID-19

The trans-omics landscape of COVID-19

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19

A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19

Integrated multiomics analysis to infer COVID-19 biological insights

Development of Single-Cell Transcriptomics and Its Application in COVID-19

[A Multi-Omics Approach to Investigate the Etiology of Non-Communicable Diseases: Recent Advance and Applications].

Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2

Mapping the vast landscape of multisystem complications of COVID-19: Bibliometric analysis

Applications of multi‐omics analysis in human diseases

Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery

Identification and Development of Therapeutics for COVID-19